Skip to main content
letter
. 2023 Jul 13;108(12):3454–3459. doi: 10.3324/haematol.2022.281944

Table 1.

Demographics and disease characteristics of patients with prior imatinib and/or dasatinib intolerance.

graphic file with name 1083454.tab1.jpg